Journals / Klimik Dergisi / 2015 / Cilt: 28 - Sayı: 3

Biomarkers in Bacterial Infections and Sepsis

Bakteriyel İnfeksiyonlarda ve Sepsiste Biyobelirteçler

Pages
96–102
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Klimik Dergisi 2015; 28(3): 96-102

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sepsis is a life threatening clinical condition which occurs as a result of systemic response to serious bacterial infection.
📊
Key Findings & Data:Increase of antibiotic use and supportive therapy has not led to a decrease in the prevalence of sepsis in the world.
💡
Conclusion & Impact:Klimik Dergisi 2015; 28(3): 96-102
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Sepsis is a life threatening clinical condition which occurs as a result of systemic response to serious bacterial infection. Increase of antibiotic use and supportive therapy has not led to a decrease in the prevalence of sepsis in the world. Because early clinical signs of sepsis are not specific, researchers are looking for new ways to diagnose sepsis earlier using biomarkers. Potential biomarkers for diagnosis of sepsis caused by bacterial infections are reviewed. Klimik Dergisi 2015; 28(3): 96-102

Özet

Sepsis, ciddi bakteriyel infeksiyona karşı sistemik yanıtın sonucu olarak ortaya çıkan ve yaşamı tehdit eden bir klinik durumdur. Tüm dünyada antibiyotik kullanımının ve destek tedavilerinin artmasına karşın sepsisin sıklığında bir azalma olmamıştır. İlk klinik bulgularının özgül olmamasından dolayı sepsisi daha erken dönemde tanımaya yönelik güncel arayışlardan birisini de biyobelirteçlerin kullanılması oluşturmaktadır. Bu derlemede bakteriyel infeksiyonlara bağlı olarak gelişen sepsisin tanısı için kullanılabilecek biyobelirteçler gözden geçirilmiştir. Klimik Dergisi 2015; 28(3): 96-102

🔖

Cite This Article

SÖNMEZER, M. Ç., TÜLEK, N. (2022). Biomarkers in Bacterial Infections and Sepsis. Klimik Dergisi, Cilt: 28 - Sayı: 3, 96–102. https://ajindex.com/articles/573607

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Dupuy AM, Philippart F, Péan Y, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infec- tions. Ann Intensive Care. 2013; 3(1): 22. Bossuyt PM, Reitsma JB, Bruns DE, et al. Standards for report- ing of diagnostic accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003; 138(1): W1-12. [CrossRef] Bachmann LM, Jüni P, Reichenbach S, Ziswiler HR, Kessels AG, Vögelin E. Consequences of different diagnostic "gold stan- dards" in test accuracy research: Carpal Tunnel Syndrome as an example. Int J Epidemiol. 2005; 34(4): 953-5.
  2. Bozza FA, Bozza PT, Castro Faria Neto HC. Beyond sepsis patho- physiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz. 2005; 100(Suppl. 1): 217-21. [CrossRef] Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care. 2005; 11(5): 473-80. [CrossRef] Marshall JC, Vincent JL, Fink MP, et al. Measures, markers, and me- diators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med. 2003; 31(5): 1560-7. [CrossRef] Cho SY, Choi HJ. Biomarkers of sepsis. Infect Chemother. 2014; 46(1): 1-12. [CrossRef] Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010; 14(1): R15. [CrossRef] Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomark- ers of sepsis in critical care. J Antimicrob Chemother. 2011; 66(Suppl. 2): ii33-40. [CrossRef] Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum pro- calcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39(2): 206-17. [CrossRef] Póvoa P. C-reactive protein: a valuable marker of sepsis. Inten- sive Care Med. 2002; 28(3): 235-43. [CrossRef] Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest. 2003; 111(12): 1805-12. [CrossRef] Smith JW, Colombo JL, McDonald TL. Comparison of serum amy- loid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients. J Clin Lab Anal. 1992;6(4):219-24. [CrossRef] Haris KR, Digard NJ, Lee HA. Serum C-reactive protein. A useful and economical marker of immune activation in renal transplan- tation. Transplantation. 1996; 61(11): 1593-600